International Symposium on Tumor Biology in Kanazawa 2019（金沢国際がん生物学シンポジウム）
下記のとおり、金沢大学がん進展制御研究所・金沢国際がん生物学研究会による国際シンポジウムを開催いたします。
シンガポール国立大学Duke-NUS Medical Schoolでがん研究部門を率いるDavid Virshup博士らによる講演が行われます。是非ご参加ください。
日時
令和元年10月29日（火）9:00 – 16:45
場所：金沢大学医学部記念館（金沢市宝町13-1）
主催
金沢大学がん進展制御研究所（KU CRI）
金沢国際がん生物学研究会
共催
金沢大学ナノ生命科学研究所（WPI-NanoLSI）
金沢大学新学術創成研究機構（InFiniti）
金沢大学法人主導型研究課題「AIと数理生物学」
文部科学省「がん専門医療人材」養成プラン－北信がんプロ－
プログラム
9:00‐9:10 Opening Remarks
Atsushi Hirao, Director of KU CRI and Principal Investigator of WPI-NanoLSI, Kanazawa University
SESSION 1
Chair: Takeshi Suzuki, KU CRI and InFiniti
9:10-9:35 Targeting mitochondrial enzumes of one-carbon metabolism for cancer treatment
Tatsunori Nishimura, KU CRI
9:35-10:00 RB1 inactivation induces a protumoral microenvironment
Chiaki Takahashi, KU CRI
10:00-10:30 Genomic and Epigenomic Alterations in Gastrointestinal Cancer: Opportunitites for Precision Oncology
Patrik Tan, Duke-NUS Medical School, Singapore
10:30-10:40 Coffee Break
SESSION 2
Chair: Naofumi Mukaida, KU CRI
10:40-11:05 Regulation of hematopoietic stem cell fate by gut microbiota-derived metabolites
Yuko Tadokoro, KU CRI and WPI-NanoLSI
11:05-11:30 Macrocyclic peptide targeting growth factor and the receptor
Kunio Matsumoto, KU CRI, WPI-NanoLSI, and InFiniti
11:30-12:00 The potential role of multi-drug resistance protein ABCB1 for tumor suppression in bats.
Koji Itahana, Duke-NUS Medical School, Singapore
12:00-13:00 Lunch
SPECIAL LECTURE
Chair: Masanobu Oshima, KU CRI and WPI-NanoLSI
13:00-13:50 Drugging the Wnt pathway – Where it helps, and what it teaches us.
David Virshup, Duke-NUS Medical School, Singapore
13:50-14:00 Coffee Break
SESSION 3
Chair: Toshinari Minamoto, KU CRI
14:00-14:25 Protective role of JLP-dependent lysosomme positioning in reactive oxygen species (ROS)-induced cell death
I Ketut Gunarta, KU CRI
14:25-14:50 Circumvention of targeted drug tolerance in lung cancer
Seiji Yano, KU CRI and WPI-NanoLSI
14:50-15:20 The polycomb repressive complex drives epigenetic convergence in blast crisis chronic myeloid leukemia
S. Tiong Ong, Duke-NUS Medical School, Singapore
15:20-15:35 Coffee Break
SESSION 4
15:35-16:00 CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functinoal validation for colorectal cancer driver genes.
Haruna Takeda, National Cancer Center Japan
16:00-16:25 The mechanism and physiological significance of programmed cell death initiated by caspase-1
Kohsuke Tsuchiya, KU CRI and InFiniti
16:25-16:35 External Panel Review
16:35-16:45 Closing Remarks
Chisato Mukai, Vice President of Kanazawa University
16:45-16:50 Photo session
ポスターはこちら